Related references
Note: Only part of the references are listed.Flunarizine versus topiramate for chronic migraine prophylaxis: a randomized trial
K.-L. Lai et al.
ACTA NEUROLOGICA SCANDINAVICA (2016)
Zhengtian Capsule versus flunarizine in patients with migraine: a multi-center, double-blind, double-dummy, randomized controlled, non-inferior clinical trial
Kegang Cao et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Drug safety and tolerability in prophylactic migraine treatment
Laszlo Vecsei et al.
EXPERT OPINION ON DRUG SAFETY (2015)
A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache
Jeffrey L. Jackson et al.
PLOS ONE (2015)
Transcutaneous Supraorbital Nerve Stimulation (t-SNS) with the Cefaly® Device for Migraine Prevention: A Review of the Available Data
Franz Riederer et al.
PAIN AND THERAPY (2015)
The International Classification of Headache Disorders, 3rd edition (beta version)
Andre Bes et al.
CEPHALALGIA (2013)
Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)
Andrew M. Blumenfeld et al.
HEADACHE (2013)
Safety and patients’ satisfaction of transcutaneous Supraorbital NeuroStimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population
Delphine Magis et al.
JOURNAL OF HEADACHE AND PAIN (2013)
Migraine prevention with a supraorbital transcutaneous stimulator A randomized controlled trial
Jean Schoenen et al.
NEUROLOGY (2013)
A Randomized, One-Year Clinical Trial Comparing the Efficacy of Topiramate, Flunarizine, and a Combination of Flunarizine and Topiramate in Migraine Prophylaxis
Ning Luo et al.
PAIN MEDICINE (2012)
Supraorbital transcutaneous neurostimulation has sedative effects in healthy subjects
Maxime Piquet et al.
BMC NEUROLOGY (2011)
Neurostimulation for Primary Headache Disorders: Part 2, Review of Central Neurostimulators for Primary Headache, Overall Therapeutic Efficacy, Safety, Cost, Patient Selection, and Future Research in Headache Neuromodulation
Brian Jenkins et al.
HEADACHE (2011)
Neurostimulation for Primary Headache Disorders, Part 1: Pathophysiology and Anatomy, History of Neuromodulation in Headache Treatment, and Review of Peripheral Neuromodulation in Primary Headaches
Brian Jenkins et al.
HEADACHE (2011)
Sustained Effectiveness of Occipital Nerve Stimulation in Drug-Resistant Chronic Cluster Headache
Delphine Magis et al.
HEADACHE (2011)
Diencephalic and brainstem mechanisms in migraine
Simon Akerman et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Pharmacological Management of Migraine Headaches
Margaret F. Moloney et al.
NURSE PRACTITIONER (2010)
EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force
S. Evers et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study
Seibu Mochizuki et al.
LANCET (2007)
Prophylactic pharmacotherapy for migraine headaches
TM Buchanan et al.
SEMINARS IN NEUROLOGY (2006)
Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements
DHG Smith et al.
JOURNAL OF HYPERTENSION (2003)
Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily
HC Diener et al.
CEPHALALGIA (2002)
Pharmacological involvement of the calcium channel blocker flunarizine in dopamine transmission at the striatum
JE Belforte et al.
PARKINSONISM & RELATED DISORDERS (2001)
Share Paper
